TTrialPathMatch Me to Trials
← Back to trials
RecruitingGlioblastoma, IDH-Wildtype

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Eligible age

18+ yrs

Accepts

All genders

Locations

9 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This phase II trial studies whether different imaging techniques can provide additional and more accurate information than the usual approach for assessing the activity of tumors in patients with newly diagnosed glioblastoma. The usual approach for this currently is magnetic resonance imaging (MRI). This study is trying to learn more about the meaning of changes in MRI scans after treatment, as while the appearance of some of these changes may reflect progressing tumor, some may be due the treatment. Dynamic susceptibility contrast (DSC)-MRIs, along with positron emission tomography (PET) and/or magnetic resonance (MR) spectroscopy, may help doctors tell which changes are a reflection of the treatment and which changes may be due to progressing tumor.

Sponsor: ECOG-ACRIN Cancer Research Group

You may qualify if…

  • ✓ Patient must be ≥ 18 years of age.
  • ✓ Patient must have a Karnofsky Performance Status ≥ 60%.
  • ✓ Patient must have newly diagnosed GBM (must be IDH wild type), with pathologic proof, based on World Health Organization (WHO) 2021 criteria.
  • ✓ Patient must be planning to receive standard-of-care treatment for newly diagnosed glioblastoma.
  • ✓ Patient must have completed an MRI prior to the diagnostic surgery for GBM and have images available for upload into Transfer of Images and Data (TRIAD).
  • ✓ Patient must have diagnostic surgery for GBM within 7 weeks prior to registration.
  • ✓ Patient must have O6-Methylguanine-DNA Methyltransferase (MGMT) methylation status ordered at time of registration.
  • ✓ Patient must have a post-operative (op) MRI completed within 3 weeks after diagnostic surgery for GBM and have images available for upload into TRIAD.

Where it's recruiting

Alabama

Birmingham

California

Los Angeles

Florida

Jacksonville · Tampa

Georgia

Atlanta

Michigan

Ann Arbor

North Carolina

Charlotte · Durham · Winston-Salem

Rhode Island

Providence

West Virginia

Huntington · Morgantown

Wisconsin

Madison · Menomonee Falls · Milwaukee · Oak Creek …

Source: ClinicalTrials.gov · NCT06319027 · last updated 2026-08-18

Identifying Findings on Brain Scans That Could Help Make Better Predic · TrialPath